- Home
- MXF vs MREO Comparison
MXF vs MREO Comparison
Compare MXF & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXF
- MREO
- Stock Information
- Founded
- MXF 1981
- MREO 2015
- Country
- MXF Mexico
- MREO United Kingdom
- Employees
- MXF N/A
- MREO N/A
- Industry
- MXF Trusts Except Educational Religious and Charitable
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- MXF Finance
- MREO Health Care
- Exchange
- MXF Nasdaq
- MREO Nasdaq
- Market Cap
- MXF 239.1M
- MREO 281.6M
- IPO Year
- MXF N/A
- MREO N/A
- Fundamental
- Price
- MXF $19.29
- MREO $1.75
- Analyst Decision
- MXF
- MREO Strong Buy
- Analyst Count
- MXF 0
- MREO 5
- Target Price
- MXF N/A
- MREO $7.40
- AVG Volume (30 Days)
- MXF 27.4K
- MREO 910.9K
- Earning Date
- MXF 01-01-0001
- MREO 11-11-2025
- Dividend Yield
- MXF 4.70%
- MREO N/A
- EPS Growth
- MXF N/A
- MREO N/A
- EPS
- MXF N/A
- MREO N/A
- Revenue
- MXF N/A
- MREO $500,000.00
- Revenue This Year
- MXF N/A
- MREO N/A
- Revenue Next Year
- MXF N/A
- MREO $55.50
- P/E Ratio
- MXF N/A
- MREO N/A
- Revenue Growth
- MXF N/A
- MREO N/A
- 52 Week Low
- MXF $14.77
- MREO $1.47
- 52 Week High
- MXF $19.49
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- MXF 73.39
- MREO 48.03
- Support Level
- MXF $17.99
- MREO $1.71
- Resistance Level
- MXF $19.44
- MREO $1.80
- Average True Range (ATR)
- MXF 0.26
- MREO 0.07
- MACD
- MXF 0.08
- MREO 0.01
- Stochastic Oscillator
- MXF 90.80
- MREO 40.91
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).